智能化患者自控镇痛中国疼痛效果综合评估量表的构建及其在术后镇痛管理中的应用OA

In February 2026,the first multicenter prospective study specifically developed for the Chinese clinical context,entitled Development and Validation of the Chinese Pain Effect Comprehensive Assessment Scale for Intelligent Pa-tient-Controlled Analgesia:A Multicenter Clinical Study,was officially published in the Chinese Journal of Pain.Based on evidence from evidence-based medicine,the Smart Chinese Pain Assessment Scale(S-CPAS)comprises 2 sections,10 dimensions,and 32 items,and demonstrates good reliability and validity.It enables a comprehensive workflow from data collection and intelligent analysis to outcome presentation,with advantages in automation,intelligence,individualiza-tion,and precision.The use of an intelligent pain assessment ward-round tablet system provides rapid assistance in anal-gesic management.This approach is expected to substantially improve the effectiveness of artificial intelligence-assisted patient-controlled analgesia(AI-PCA)and precision multimodal analgesia(PMA).In the future,we advocate the im-plementation of the innovative S-CPAS and the establishment of a collaborative postoperative analgesia management model integrating a virtual pain unit(VPU)with an acute pain service(APS).These efforts may promote the high-quality de-velopment of intelligent PM A in clinical practice and enable patients to benefit from safer,more effective,higher-quali-ty,and more rapid analgesic care.